The billionaire investor Mr. Ackman's Pershing Square Capital Management was one of the largest stock holders of Valeant Pharmaceuticals. Ackman has perceptively made his position in Valeant far more important by raising its stake from 5.7% to 9.9% recently. Now, Pershing is the second largest shareholder in Valeant followed by Sequoia Fund led by Ruane, Goldfarb and Cuniff.
Citron Research
Breaking News
Subscribe to VCpost newsletter
Most Popular
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Canadian Family Receives Wrong Remains After Father Died While on Vacation in Cuba
- Baltimore Sues Dali Cargo Ship Owner and Manager for Negligence That Led to Key Bridge Collapse
- Delta Air Lines Increases Flight Attendant, Ground Workers Wages by 5%, Boosts Starting Pay
- Construction Commences on Multi-Billion Dollar High-Speed Rail Line Connecting Las Vegas and Los Angeles
- Tesla Uses New State Law to Bypass Austin's Environmental Regulations at Texas Gigafactory
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- JetBlue Ex-CEO Robin Hayes Appointed to Head Airbus’s North American Division